Reversal of Neuromuscular Blockade by Sugammadex after Continuous Infusion of Rocuronium in Patients Randomized to Sevoflurane or Propofol Maintenance Anesthesia
- 1 July 2009
- journal article
- research article
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 111 (1) , 30-35
Abstract
Background: Sugammadex rapidly reverses neuromuscular blockade induced by bolus rocuronium doses, but it has not been investigated after continuous rocuronium infusion in surgical patients. We therefore examined the clinical effect of sugammadex for neuromuscular blockade induced by continuous rocuronium infusion in adults undergoing surgery under maintenance anesthesia with sevoflurane or propofol. Methods: This four-center, comparative, parallel-group study, randomly assigned 52 adult patients (American Society of Anesthesiologists Class I-III) to maintenance anesthesia with sevoflurane or propofol. Neuromuscular blockade was induced by bolus injection of 0.6 mg/kg rocuronium followed by continuous infusion of 7 microg x kg(-1) x min(-1) rocuronium adjusted to maintain a neuromuscular blockade depth of zero response to train-of-four and a posttetanic count of no more than 10 responses. A single dose of 4 mg/kg sugammadex was administered at first twitch (T1) 3-10%. The primary clinical effect variable was recovery time to a train-of-four ratio of 0.9. Results: Median recovery time from start of sugammadex administration to a train-of-four ratio of 0.9 in the sevoflurane and propofol groups was 1.3 and 1.2 min, respectively. The estimated difference in recovery time between groups was 9 s (95% confidence interval -6 to 20 s), entirely within the predefined equivalence interval. Median plasma rocuronium concentration just before sugammadex administration was 33% lower during maintenance anesthesia with sevoflurane than with propofol. Sugammadex was well tolerated. One adverse event (procedural hypotension) was considered to be probably related to sugammadex. Conclusions: Single-dose sugammadex (4 mg/kg) after continuous rocuronium infusion is equally effective and well tolerated during maintenance anesthesia with sevoflurane or propofol.Keywords
This publication has 16 references indexed in Scilit:
- Early Reversal of Profound Rocuronium-induced Neuromuscular Blockade by Sugammadex in a Randomized Multicenter Study: Efficacy, Safety, and PharmacokineticsAnesthesiology, 2007
- Reversal of Rocuronium-Induced Neuromuscular Block with the Novel Drug Sugammadex Is Equally Effective Under Maintenance Anesthesia with Propofol or SevofluraneAnesthesia & Analgesia, 2007
- Effective Reversal of Moderate Rocuronium- or Vecuronium-induced Neuromuscular Block with Sugammadex, a Selective Relaxant Binding AgentAnesthesiology, 2007
- Chemical encapsulation of rocuronium by synthetic cyclodextrin derivatives: reversal of neuromuscular block in anaesthetized Rhesus monkeysBritish Journal of Anaesthesia, 2005
- Reversal of Neuromusclar Blockade and Simultaneous Increase in Plasma Rocuronium Concentration after the Intravenous Infusion of the Novel Reversal Agent Org 25970Anesthesiology, 2003
- Reversal agents for nondepolarizing neuromuscular blockade: Reasons for and development of a new conceptSeminars in Anesthesia, Perioperative Medicine and Pain, 2002
- A Novel Concept of Reversing Neuromuscular Block: Chemical Encapsulation of Rocuronium Bromide by a Cyclodextrin‐Based Synthetic HostAngewandte Chemie International Edition, 2002
- Neostigmine antagonism of rocuronium block during anesthesia with sevoflurance, isoflurane or propofolCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 2001
- Neuromuscular blocking effects of rocuronium during desflurane, isoflurane, and sevoflurane anaesthesiaCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 1998
- Administration of rocuronium (Org 9426) by continuous infusion and its reversibility with anticholinesterasesAnaesthesia, 1994